Download PDF
Anästhesiol Intensivmed Notfallmed Schmerzther 2010; 45(2): 88-90
DOI: 10.1055/s-0029-1243381
Fachwissen
Schmerztherapie
© Georg Thieme Verlag Stuttgart · New York

Ambulante Schmerztherapie. Behandlung bei penetrierendem Rektum-Karzinom mittels Periduralkatheter

Ambulatory pain therapy in penetrating rectal cancer via epidural anesthesiaReinhard Abel, Gregor Abt, Karl Peter Ittner, Christoph H.R. Wiese, Bernhard M. Graf, Michael T. Pawlik
Further Information

Publication History

Publication Date:
12 February 2010 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Im Rahmen der Tumorschmerztherapie kommen immer wieder auch invasive Techniken zum Einsatz. Wir berichten über die Schmerztherapie bei einer 55-jährigen Patientin mit penetrierendem Rektum-Karzinom mittels kontinuierlicher lumbaler Periduralanästhesie. Nach Anlage und Einstellung im Krankenhaus erfolgte die weitere Behandlung über insgesamt 7 Wochen im häuslichen Umfeld.

Abstract

Treatment of cancer pain includes invasive techniques of pain therapy if necessary. Here we report the management of a 55-year-old female patient with penetrating rectal cancer using continous lumbal epidural anesthesia. After placement and dose-finding our patient was discharged from hospital and further treatment occured at home.

Schlüsselwörter

Ambulante Schmerztherapie - palliativ - Periduralkatheter - Rektum-Karzinom

Keywords

Ambulatory pain therapy - palliative - peridural catheter - rectal cancer

Weiteres Material zum Artikel

Literatur

  • 1 Bonica JJ.. Cancer Pain.. In: Fibiger L, (Hrsg.) The Management of Pain.. London/Philadelphia; 1990: 400-460
    Google Scholar
  • 2 Schug SA, Zech D, Dorr U.. Cancer pain management according to WHO analgesic guidelines.  J Pain Symptom Manage. 1990;  5 27-32
    CrossrefPubMedGoogle Scholar
  • 3 Miguel R.. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder?.  Cancer Control. 2000;  7 149-156
    PubMedGoogle Scholar
  • 4 Jocham HR, Dassen T, Widdershoven G et al.. Quality of life in palliative care cancer patients: a literature review.  J Clin Nurs. 2006;  15 1188-1195
    CrossrefPubMedGoogle Scholar
  • 5 McNicol E, Horowicz-Mehler N, Fisk RA et al.. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.  J Pain. 2003;  4 231-256
    CrossrefPubMedGoogle Scholar
  • 6 Ohnesorge H, Siebrecht D, Gleim M.. Tumor pain therapy.  Anasthesiol Intensivmed Notfallmed Schmerzther. 2003;  38 (Quiz 435–437)
    PubMedGoogle Scholar
  • 7 Kress HG.. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.  Eur J Pain. 2009;  13 219-230
    CrossrefPubMedGoogle Scholar
  • 8 Downing JE, Busch EH, Stedman PM.. Epidural morphine delivered by a percutaneous epidural catheter for outpatient treatment of cancer pain.  Anesth Analg. 1988;  67 1159-1161
    PubMedGoogle Scholar
  • 9 Smitt PS, Tsafka A, Teng-van de Zande F et al.. Outcome and complications of epidural analgesia in patients with chronic cancer pain.  Cancer. 1998;  83 2015-2022
    CrossrefPubMedGoogle Scholar
  • 10 Ruppen W, Derry S, McQuay HJ, Moore RA.. Infection rates associated with epidural indwelling catheters for seven days or longer: systematic review and meta-analysis.  BMC Palliat Care. 2007;  6 3
    CrossrefPubMedGoogle Scholar
  • 11 Crul BJ, Delhaas EM.. Technical complications during long-term subarachnoid or epidural administration of morphine in terminally ill cancer patients: a review of 140 cases.  Reg Anesth. 1991;  16 209-213
    PubMedGoogle Scholar

Reinhard Abel
Dr. med. Gregor Abt
PD Dr. med. Karl Peter Ittner
Dr. med. Christoph H. R. Wiese
Prof. Dr. med. Bernhard M. Graf
Dr. med. Michael T. Pawlik

Email: reinhard.abel@klinik.uni-r.de

Email: gregor.abt@klinik.uni-r.de

Email: karl-peter.ittner@klinik.uni-r.de

Email: Christoph.Wiese@klinik.uni-regensburg.de

Email: michael.pawlik@klinik.uni-r.de

>